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Cyclic AMP-dependent protein kinase (PKA) is regu-
lated in part by N-terminal myristylation of its cata-
lytic (C) subunit. Structural information about the
role of myristylation in membrane targeting of PKA
has been limited. In mammalian cells there are four
functionally non-redundant PKA regulatory sub-
units (RIa, RIb, RIIa, and RIIb). PKA is assembled
as an inactive R2C2 holoenzyme in cells. To explore
the role of N-myristylation in membrane targeting of
PKA holoenzymes, we solved crystal structures
of RIa:myrC and RIIb2:myrC2, and showed that the
N-terminal myristylation site in the myrC serves as
a flexible ‘‘switch’’ that can potentially be mobilized
for membrane anchoring of RII, but not RI, holoen-
zymes. Furthermore, we synthesized nanodiscs and
showed by electron microscopy that membrane tar-
geting through the myristic acid is specific for the RII
holoenzyme. This membrane-anchoring myristyla-
tion switch is independent of A Kinase Anchoring
Proteins (AKAPs) that target PKA to membranes by
other mechanisms.
INTRODUCTION
More than 500 eukaryotic protein kinases are encoded by the hu-
man genome (Manning et al., 2002), and the activity and localiza-
tion of most are highly regulated by post- and co-translational
modifications as well as by adjacent domains and motifs.
While the role of phosphorylation in kinase activation has been
extensively studied, the mechanistic details of acylation and
membrane anchoring are less clear. Myristylation, the irrevers-
ible enzymatic attachment of myristic acid onto the N-terminal
glycine of target proteins (Farazi et al., 2001; Li et al., 2007;
Song et al., 1997), enhances the association of the target
with membranes (Resh, 1994). Myristylation typically occurs
co-translationally, although it can also occur in conjunction
with caspase cleavage (Harada et al., 1999). The cyclic AMP
(cAMP)-dependent protein kinase (PKA) catalytic (C) subunit
was the first myristylated protein to be identified (Carr et al.,
1982), andmost non-receptor tyrosine kinases are also N-myris-
tylated. In the free myristylated subunit (myrC) the acyl group isStructure 23, 1563–15docked into a hydrophobic allosteric pocket that penetrates
into the large lobe of the conserved kinase core (Bastidas
et al., 2012; Bossemeyer et al., 1993), and myrC does not
strongly associate with membranes. In cells, however, PKA
exists not as free C subunit but as an inactive holoenzyme with
regulatory (R) subunit dimers that are bound to two C subunits.
Activation of the R2C2 holoenzyme is mediated by cAMP binding
to the R dimer causing a conformational change that unleashes
the catalytic activity, but does not necessarily cause the C sub-
units to dissociate (Smith et al., 2013; Vigil et al., 2004). Early
fluorescence studies showed that the N terminus of myrC can
become accessible to membranes when it is part of a holoen-
zyme complex, but did not address whether this phenomenon
was isoform specific (Gangal et al., 1999).
In mammalian cells there are four functionally non-redundant
R subunits (RIa, RIb, RIIa, and RIIb), which contribute signifi-
cantly to PKA signaling specificity (Amieux et al., 2002). In gen-
eral, RII subunits are targeted at membranes in close proximity
to receptors, transporters, and channels while RI subunits tend
to be more cytosolic and dynamically recruited to membranes
(Taylor et al., 2012). RII subunits typically bind with high affinity
(low nM) to A Kinase Anchoring Proteins (AKAPs), which also
recruit other signaling proteins such as phosphatases and phos-
phodiesterases to membranes (Taylor et al., 2012). For PKA it is
essential that we now think in terms of these ‘‘signalosomes’’
rather than free R and C subunits. Here, we ask whether myris-
tylation also contributes to membrane anchoring and, if so,
whether this anchoring is isoform specific. All PKA R subunits
share the same domain organization: an N-terminal dimeriza-
tion/docking (D/D) domain followed by a flexible linker containing
an inhibitor site and two conserved cyclic nucleotide-binding
(CNB) domains (Canaves and Taylor, 2002). The recently solved
RIa, RIb, and RIIb tetrameric holoenzyme structures show that
the quaternary structures of each holoenzyme are distinct
(Boettcher et al., 2011; Ilouz et al., 2012; Zhang et al., 2012),
and the quaternary constraints imposed by the holoenzyme
create somewhat different allosteric mechanisms for activa-
tion (Taylor et al., 2012). Given our new appreciation of the
importance of the full-length PKA holoenzymes and their
ability to nucleate targeted signalosomes, we revisited the role
of myristylation.
The C subunit has a conserved core consisting of an N and
C lobe that is shared by all eukaryotic protein kinases. The
conserved core is flanked by N- and C-terminal tails (N tail and
C tail). While the C tail is a highly conserved feature of all PKA
C subunits and of every AGC kinase, the N tail (residues 1–39)72, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1563
Figure 1. Domain Organization and Structure of PKA myrC Subunit
(A) Domain organization of myrC subunit.
(B) The myristic acid (myr) is docked into a hydrophobic pocket of the myrC
subunit (left) (PDB: 4DG2). The A helix at the N terminus of C subunit (right) can
serve as an AKIP binding site and harbors numerous co- and post-translational
modifications. The Myr motif is shown in teal.is variable even within different mammalian PKA isoforms
(Soberg et al., 2013). Residues 1–13 correspond to the first
exon and constitute a myristylation motif (Myr motif), which in-
cludes the N-terminal Gly as well as basic amino acids that are
important for strengthening the membrane-anchoring potential.
Most C-subunit isoforms are myristylated but some are not,
and a recent C subunit in liver cancer was shown to be a fusion
protein wherein the first 14 residues (exon 1) are replaced with
the J domain of DNAJB1 (Honeyman et al., 2014). A dominant
feature of the N tail (exons 1 and 2) is a long amphipathic A helix,
which in the active kinase is anchored through its hydrophobic
surface to both lobes of the kinase core (Herberg et al., 1997).
This N tail is rich in signaling information (Figure 1). The A helix
binds through its hydrophilic surface to another protein, the
A kinase interacting protein (AKIP), which is important for PKA
shuttling between the cytoplasm and the nucleus (Sastri et al.,
2005). The N tail also harbors numerous co- and post-transla-
tional modifications that, in addition to myristylation, include
deamidation of Asn2 and phosphorylation of Ser10, and these
modifications can contribute in a variety of ways to PKA function
(Bastidas et al., 2012, 2013; Gangal et al., 1999; Pepperkok et al.,
2000; Tholey et al., 2001). Here we focus on myristylation.
Our structural knowledge about the role of myristylation in
membrane targeting of PKA has so far been limited to the free
myrC and complexes with nucleotide and/or small peptides
(IP20 or SP20) (Bastidas et al., 2012; Bossemeyer et al., 1993).
Based on fluorescence anisotropy in solution, Johnson and col-
leagues predicted earlier that association with membranes was
enhanced in the holoenzyme and that membrane association
would be isoform specific (Gangal et al., 1999). In this study,
we further elucidate the role of N-myristylation in membrane
targeting of PKA holoenzymes by crystallizing myrC with RIa
and RIIb. We specifically solved crystal structures of an RIa het-
erodimer (RIa:myrC) and a full-length RIIb holoenzyme (RIIb2:1564 Structure 23, 1563–1572, September 1, 2015 ª2015 Elsevier LtmyrC2). The RIa:myrC heterodimer shows that the Myr motif is
sequestered in the acyl pocket similar to myrC. By contrast,
the entire Myr motif is expelled from the acyl pocket in the RIIb
complex and is not visible, presumably due to its flexibility. To
confirm that this isoform-specific conformational switch also
facilitates binding to membranes, we synthesized nanodiscs,
and used them to show by gel filtration and electron microscopy
that membrane targeting through the myristic acid is specifically
associated with the RIIb holoenzyme. In addition, the C terminus
of the RIIb holoenzyme, but not the RIa holoenzyme, is flexible.
The C terminus of each R subunit provides a helical capping
motif for the bound cAMP in the activation loop. In the holoen-
zymes this capping motif is in close proximity to the N-terminal
Myr motif in myrC. In RIa the capping motif is stabilized in
an inactive conformation, whereas in the RIIb holoenzyme the
C-terminal capping motif is also disordered. Together the results
define a bivalent conformational membrane-targeting myris-
tylation switch that is mobilized specifically in PKA type II holo-
enzymes and is independent of AKAPs. This is similar to the
calcium-mobilized myristylation switch in recoverin and the
inositol-triphosphate-induced myristylation switch in HIV-gag.
The nearby disordered capping motif at the C terminus of
the RIIb subunit provides additional opportunities for protein-
membrane interactions at this interface and opens the potential
for interactions with other acyl groups that target myristylated,
farnisylated, and palmitylated proteins to membranes.
RESULTS
RIa:myrC Heterodimer Structure
To better define themyristylation site in an RIa complex, we crys-
tallized an R:C heterodimer of myrC with a deletion mutant of
RIa. As explained in Experimental Procedures, two mutations
were introduced. In the deletion mutant of RIa, RIa(91–379),
and Arg333 in the CNB-B domain was replaced with Lys as pre-
viously described (Kim et al., 2007). For myrC we used the K7C
mutant because it expressed at higher levels. The crystal struc-
ture of the RIa:myrC was solved at 2.4 A˚ (Figure 2A and Table 1).
In the RIa:myrC structure the myristylated N terminus is well or-
dered (Figure 2B), while in the same heterodimer structure with
the non-myristylated C subunit the first 12 residues are disor-
dered (Kim et al., 2007) (PDB: 2QCS). This is similar to the pre-
vious observation that myristylation stabilizes the N-terminal
residues of the myrC subunit no matter whether the myrC sub-
unit is alone or bound to a small PKA substrate peptide, SP20
(Bastidas et al., 2012) or to a high-affinity inhibitor peptide,
IP20. Specifically the RIa:myrC structure reveals a conformation
that includes the entire N terminus as well as the myristic acid
and the hydrophobic side chains that line the acyl pocket; all
elements are well resolved in the electron density (Figure 2B).
As in the RIa(91–379) complex with the non-myristylated C sub-
unit, both CNB domains are locked into stable inactive confor-
mations where the helical motif that provides a capping residue
for the bond cAMP is locked into an inactive conformation.
Although the overall RIa:myrC(K7C) heterodimer closely re-
sembles thepreviously solvedmyrC(K7C) in themyrC(K7C):SP20
structure, the conformations of the N termini nevertheless differ
somewhat in these two structures (Figures 2C and 2D). The N ter-
minusof themyrC(K7C):SP20structuredisplaysahelix-turn-helixd All rights reserved
Figure 2. Crystal Structure of RIa:myrC Showing Docked Myristic Acid
(A) Side view of the RIa:myrC structure (PDB: 4X6R). The myristyl acid is shown in yellow. The N lobe of the C subunit is white; the C lobe and C tail are tan. The
R subunit is cyan.
(B) Electron density 2Fo-Fc map of the myristic acid and N terminus of C subunit at 1.0s level.
(C) The myristic acid binds within its previously defined hydrophobic pocket.
(D) Overlay of the RIa:myrC (teal; myristic acid is shown in yellow) and myrC:SP20 (tan; myristic acid is shown in sand). These two structures display different
conformations at the N terminus of the C subunit.motif following the myristate with the A helix starting at Glu1. The
RIa:myrC structure is missing the first helix; instead the A helix
starts at Lys8and is precededby a loop. Theposition of theC-ter-
minal region of themyristic acid, including the ester bond toGly1,
is dislodged from the A helix while the acyl chain binds within its
previously defined hydrophobic pocket. We also compared the
flexibility of residues at theN terminus and near themyristyl-bind-
ing pocket for effects of N-myristylationwhenbinding to the small
peptide SP20 versus the pseudosubstrate RIa. Even though or-
dered, theB factors at theN terminus are greater for theRIa:myrC
structure (105 A˚2) than for themyrC(K7C):SP20structure (30.2 A˚2)
despite similar overall B values (50 A˚2).
RIIb2:myrC2 Holoenzyme Structure
Previous fluorescence anisotropy studies suggested that
binding of the RIIb subunit causes the N-terminal myristylated
tail to become more flexible and dynamic in solution, and, in
contrast to free C and the RIa tetramer, association with mem-
branes was further enhanced in RII holoenzyme complexes
(Gangal et al., 1999). To confirm structurally whether themyristy-
lated N terminus is ordered or disordered in the RIIb holoenzyme
structure, we thus crystallized the RIIb holoenzyme with the
myristylated C subunit. The crystal structure of the tetrameric
RIIb(R230K)2:myrC(K7C)2 holoenzyme (labeled as RIIb2:myrC2)
was solved at 2.5 A˚ (Figure 3A and Table 1). Even though the
entire myristylated N terminus was present in the protein, resi-
dues 1–13 of the myrC subunit (GNAAAAKKGSEQE) as well as
the myristic acid are not visible in the RIIb2:myrC2 structure (Fig-
ure 3B). Thus binding to RIIb selectively displaces the entire
Myr motif, leaving it more flexible and accessible to solvent.
This is unique to the RIIb2:myrC2 holoenzyme. It is differentStructure 23, 1563–15from the previously reported structures of the myrC subunit
alone, the myrC bound to SP20 or IP20 (Bastidas et al., 2012,
2013; Bossemeyer et al., 1993), and myrC bound to RIa, which
all show a more stable Myr motif that is anchored into the
acyl pocket in the C lobe of C subunit (Bastidas et al., 2013)
(Bastidas et al., 2012; Bossemeyer et al., 1993). The overall
RIIb2:myrC2 structure closely resembles the RIIb2:C2 structure
(Zhang et al., 2012) with a Ca root-mean-square deviation of
0.19 A˚ and the largest matching Ca atoms distance of 1.2 A˚.
The C subunit still remains in a closed conformation even though
there is no nucleotide bound to the active site, and still has low B
factors (50 A˚2), which is similar to the overall B values in both
the C and N lobe. Furthermore, the N termini of the C subunits
in each of the RIa:myrC and RIIb2:myrC2 structures have no in-
teractions with neighboring molecules in the crystal packing,
so it is unlikely the N terminus is ordered or disordered due to
crystal contacts.
Since the RIIb holoenzyme is typically targeted by AKAPs
to membranes, the exposed myristyl chains could thus pro-
vide additional opportunities for bivalent membrane anchoring.
Based on our structure, we hypothesized that myristylation
may in fact provide an alternative and/or complementary mech-
anism for targeting RII holoenzymes directly to membranes in
addition to or independent of AKAPs, which are known to target
RII holoenzymes in close proximity to membranes.
C-Terminal Capping Motif in the R Subunit Is Also
Disordered in the RIIb Holoenzyme but Ordered in the
RIa Holoenzyme
There is another difference between the RIa holoenzyme
complexes and the RIIb holoenzyme. In the R subunits, major72, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1565
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a, b, g () 90.0, 90.0, 120.0 90.0, 90.0, 90.0
Average redundancy 3.6 4.0
No. of unique reflections 48,209 31,571
Resolution (A˚) 2.4 2.5
Rsym
a 0.068 (0.47)b 0.095 (0.49)b
Completeness (%) 99.2 (94.6)b 95.2 (93.1)b
I/s 15.9 (3.4)b 19.8 (3.3)b
Refinement
Resolution (A˚) 63.0–2.4 40.0–2.5
Rwork
c/Rfree
d (%) 18.4/23.4 19.8/26.1
No. of protein atoms 5,269 4,918
Ligand and ion MgATP None
No. of water atoms 529 76
Root-mean-square deviations
Bond lengths (A˚) 0.019 0.011
Bond angles () 1.15 1.35
Average B factor 44.6 57.0
Ramachandran Angles (%)
Most favored (%) 98.2 95.9
Disallowed none none
aRsym = ShSijI(h)  I(h)ijIShSi I(h)i, where I(h) is the mean intensity after
rejections.
bNumbers in parentheses correspond to the highest-resolution shell
of data.
cRwork = ShjjFobs(h)j  jFcalc(h)jjIShjFobs(h)j; no I/s cutoff was used during
refinement.
d5.0% of the truncated dataset was excluded from refinement to
calculate Rfree.conformational changes are associated with the CNB domains
as the protein toggles between its active (cAMP-bound) state
and its inactive (holoenzyme) state (Berman et al., 2005; Kornev
and Taylor, 2010). In the active or cAMP-bound conformation,
cAMP is bound to the phosphate-binding cassette (PBC) and
the adenine ring is capped by a hydrophobic residue. In every
CNB-B domain, this capping residue (TYR397 in RIIb) is located
in a C-terminal helix (aC00) (Figure 4A). The two CNB domains
interact closely in this active conformation, whereas the CNB
domains undergo a major conformational change in the holoen-
zyme that causes them to extend away from each other due to an
extended aBC helix in CNB-A (Figures 4B and 4C). In the RIa
holoenzyme, the reorganized C-terminal helical motif is packed
against the PBC and well ordered (Figure 4C). Thus the C-ter-
minal motif of the RIa subunit and N-terminal motif of the
myrC, which are in close proximity, are both ordered. In contrast,1566 Structure 23, 1563–1572, September 1, 2015 ª2015 Elsevier Ltin the RIIb holoenzyme, most of the C-terminal helical motif
(residues 394–416), including the capping TYR397, is disordered
(Figure 4C). These two flexible regions, the N-terminal Myr motif
in the myrC subunit and the C-terminal helical motif in RIIb, are
thus in relatively close proximity, and open up the opportunity
for interaction with other proteins that may also be anchored to
membranes.
Effect of C-Subunit Myristylation and Holoenzyme
Formation on Membrane Binding
To determine whether the Myr motif in RIIb selectively serves as
a myristylation switch and enables the membrane-anchoring
properties of the myristylated C subunit, we prepared nanodiscs
to explore whether the various PKA complexes as well as free
myrC subunit could bind to the nanodisc lipid bilayer. Specif-
ically, the nanodiscs (Nath et al., 2007) are discrete, 10-nm
diameter, model membranes that consist of phospholipid bila-
yers encircled by membrane scaffold protein, a modified amphi-
pathic peptide from apolipoprotein A-I (Nath et al., 2007). The
PKA myrC, RIa2:myrC2, and RIIb2:myrC2 were then incubated
with the nanodisc membrane scaffold protein (MSP) and lipids.
To confirm that membrane association was due specifically to
the myristic acid, we also incubated the non-myr C subunit
and the two holoenzymes formed with non-myristylated C sub-
unit, RIa2:C2 and RIIb2:C2, with the nanodiscs. Assembly of the
PKA with the nanodisc was assessed initially by gel filtration
and confirmed by SDS-PAGE (Figure 5A and Figure S1). Among
all these tested proteins, only RIIb2:myrC2 associated with the
nanodiscs (Figure 5A and Figure S1). Association of RIIb2:myrC2
with the nanodisc was further confirmed by imaging negative-
stained preparations by electron microscopy (Figure 5B). In
negative-stained electron micrographs, we observed a round
density with a diameter of 120 A˚ for the empty nanodiscs,
whereas the nanodiscs that assembled with RIIb2:myrC2 were
more heterogeneous, with diverse diameters ranging up to
250 A˚, confirming the binding of the holoenzyme. The distinct dif-
ference between the empty nanodiscs and those bound to RIIb
holoenzyme suggests that RIIb2:myrC2 binding can alter the lipid
structure. Since we do not see PKA holoenzyme beside the
nanodiscs, we suggest that the binding is perpendicular to the
lipid bilayer surface, although it remains to be determined how
exactly the binding of RIIb2:myrC2 caused the distortion of the
nanodiscs.
DISCUSSION
Because myristylation is added co-translationally, the modifica-
tion is carried throughout the lifetime of a protein, in contrast to
palmitoylation. Our results described here provide new insights
into the role of the myristic acid group and the dynamic proper-
ties of the N-terminal tail of the C subunit. The N-terminal 13 res-
idues including the myristic acid are not visible in the electron
density in theRII holoenzyme, indicating that this segment is flex-
ible. By contrast, the N terminus and myristic acid are ordered
and visible in the electron density in the RI holoenzyme and in
the myrC subunit in complex with an inhibitor peptide (IP20/
SP20) (Bastidas et al., 2012). Our results therefore suggest that
the dynamic properties of the N-terminal Myr motif are isoform
specific. While we do not yet know the detailed mechanismsd All rights reserved
Figure 3. Crystal Structure of the RIIb2:myrC2 Holoenzyme
(A) The N lobe of the C subunit is shown in white; the C lobe and C tail are shown in tan. The R subunit is shown in cyan. PDB: 4X6Q.
(B) 2Fo-Fc Electron density maps of the previously defined hydrophobic pocket where the myristic acid exists at the 1.0s (top), 0.75s (middle), and 0.5s (bottom)
level, respectively. The density of Myr motif and the myristyl density (yellow) are missing.that account for this finding, we note that the C terminus of the
RIIb subunit is also much more dynamic in the holoenzyme
than in the RI holoenzyme complex, and these two flexible
elements are in close proximity. Thus there are opportunities
for additional interactions. Little is known about the specific
mechanisms for acyl groups interacting with membranes and
membrane proteins, but the availability of many new structures
of membrane proteins now allow us to explore this phenomenon
in more depth.
We hypothesized that the enhancedmobility of the N terminus
in RII subunits could aid in membrane association due to the
exposed myristic acid group. Confirming this hypothesis, we
showed that the RII subunits can bind to nanodiscs but only in
complex with the myristylated C subunit. Therefore, RII sub-
units can bind to membranes independent of AKAPs, which
was also suggested by previous fluorescence polarization
studies (Gangal et al., 1999). The nanodisc-binding assays are
also consistent with the myrC and RIa:myrC structures where
the N terminus and myristic acid group are ordered and not
solvent exposed; neither bind to the nanodiscs. These results
demonstrate a clear functional difference between the RI and
RII isoforms. Only the RII holoenzyme has a ‘‘myristylation
switch’’ (Figure 6) for membrane anchoring. This expulsion of
the myristic acid group poises the RII holoenzyme for interaction
with membranes. Furthermore, the dynamic C terminus of the
RIIb subunit in the RIIb holoenzyme suggests that there may
be additional factors that contribute to a membrane-protein
interface or a protein-protein interface with an as yet unknown
binding partner. In contrast, the RIa has a type II PDZ motif at
its C terminus, and in this holoenzyme only the terminal four
residues are accessible for docking to another protein.
Like Src kinase, association of myristylated proteins with
membranes usually requires a patch of basic amino acidsStructure 23, 1563–15(Resh, 1994). Indeed, the C subunit also has a group of basic res-
idues lining the A helix and the surface of the C subunit near the
N terminus. In the RIIb2:myrC2 holoenzyme, the Lys residues in
the N terminus of the A helix (GNAAAAKKG) also become very
dynamic, which could further aid in the insertion of the myristic
acid group into membranes. The N terminus of the C subunit
contains several other potential post-translational modification
sites that could act to regulate this membrane-binding property
of RII subunits. These include phosphorylation of Ser10 and dea-
midation of Asn2. Phosphorylation of Ser10, in addition to almost
certainly destabilizing the observed ordered conformations of
the N terminus (Figure 6), could prevent membrane binding
through the added negative charges. In addition, deamidation
of Asn2 may cause a similar destabilizing effect on the N termi-
nus due to the close proximity of the added negative charge
to the myristic acid group. Furthermore, the deamidated form
of PKA purified from tissues can autophosphorylate at Ser10
(Toner-Webb et al., 1992), suggesting that Ser10 phosphoryla-
tion and Asn2 deamidation may act synergistically to prevent
membrane binding. Therefore, there may be interplay between
N-terminal myristylation and other N-terminal modifications.
While Thr197 and Ser338 are constitutively phosphorylated in
mammalian cells, phosphorylation of Ser10 tends to be more
transient and associated with specific cells (Breitenlechner
et al., 2004; Kinzel et al., 2000; Tholey et al., 2001). Phosphory-
lation of Ser10 has not been observed from PKA purified from
tissues; however, most of the protein is autophosphorylated on
Ser10 when the non-myristylated C subunit is expressed in bac-
teria (Yonemoto et al., 1993). Alignment of the myrC(K7C):SP20
and myrC(WT):SP20 structures (Figure 6A) reveals that they
display the same conformation of the N terminus of the C sub-
unit. The distance between the Ser10 side chain and back-
bone carbonyl of residue 7 is around 2.8 A˚ (Figure 6A). In the72, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1567
Figure 4. The C terminus of R Subunits
(A) (Upper) Sequence alignment of four R-subunit
isoforms. Helices observed in crystal structures for
RIa (1RGS) and RIIb (1CX4) are shown as red
cylinders. Capping residues in aC00 are shaded.
(Lower) Helical propensity for R subunits predicted
by AGADIR (Lacroix et al., 1998). Sequence for RIa
is shown along the x axis.
(B) In the active or cAMP-bound RIa (left) and RIIb
(right) conformation, cAMP is bound to the PBC
and the adenine ring is capped by a hydrophobic
residue. In every CNB-B domain, this capping
residue (TYP 371 in RIa, TYR 397 in RIIb) is located
in aC00.
(C) In the RIa holoenzyme (left), the reorganized
C-terminal helical motif is packed against the PBC
and well ordered, whereas in the RIIb holoenzyme
(right), most of the C-terminal helical motif (resi-
dues 394–416), including the capping TYR397, is
disordered. The flexible N-terminal Myr motif in the
myrC subunit and C-terminal helical motif in RIIb
are in relatively close proximity.RIa:myrC(K7C) structure, between the side chain hydroxyl
group of Ser10 and Cys7, Ser10 also forms weak hydrogen-
bonding with Cys7 even though the N-terminal conformation
is different from the myrC(K7C) and myrC(WT) structures. The
H-bonding interaction of Ser10 and residue 7 may help in the
ordering of the N terminus and in stabilizing the myristyl
acid. Phosphorylation of Ser10 would almost certainly destabi-
lize this conformation by disrupting the interactions between
Ser10 and other N-terminal residues. This is consistent with
recent nuclear magnetic resonance studies (Gaffarogullari
et al., 2011) on the myristylated C subunit, which suggested
that Ser10 phosphorylation destabilizes the N terminus of PKA
and causes the myristic acid to be dislodged from its hydro-
phobic pocket. More importantly, Ser10 phosphorylation and1568 Structure 23, 1563–1572, September 1, 2015 ª2015 Elsevier Ltd All rights reservedmyristylation do not occur together in
our bacterial co-expression system for
recombinant myristylated protein (Basti-
das et al., 2012; Yonemoto et al., 1993).
This is also consistent with our recent
finding that eliminating Ser10 phos-
phorylation, which is caused by K7C mu-
tation and thus has the PKA recognition
sequence abolished, increased the total
yield of myristylated C protein (Bastidas
et al., 2012). Based on previous studies
with Src, phosphorylation at Ser10 would
prevent association of the myristylated
N tail with membranes (Resh, 1994). In
the RIIb2:myrC2 holoenzyme structure
(Figures 3 and 6), however, Ser10 density
is missing together with myristic acid
and the Myr motif, due to their dynamic
properties, possibly making the RIIb2:
myrC2 more accessible to membrane
binding. Only the RII holoenzyme has
the myristic acid and Myr motif in an
‘‘out’’ conformation.Localization of the PKA holoenzyme complex tomembranes is
further mediated by specific AKAPs. The RIa holoenzyme is not
capable of contributing to its own localization through myristyla-
tion-membrane interaction because the myristic acid group is
docked into the hydrophobic pocket. However, RI holoenzymes
can be targeted to the plasma membrane via binding to dual-
specific or RI-specific AKAPs, such as smAKAP. smAKAP is
small, has N-terminal myristylation and palmitoylation sites,
and selectively binds to RI with high affinity (1–2 nM) (Figure 7)
(Burgers et al., 2012). When the RIIb holoenzyme is targeted by
AKAPs to membrane proteins, the exposed myristic acid groups
will likely be on the same surface as the AKAP. This configuration
would provide a mechanism for bivalent membrane anchoring in
addition to AKAP targeting (Figure 7).
Figure 5. Membrane Anchoring of RIIb2:-
myrC2 Holoenzyme
(A) Size-exclusion chromatography shows assem-
bly of RIIb2:myrC2 to nanodiscs. Peak1, peak 2,
and peak 3 contain protein and lipid aggregation,
RIIb2:myrC2 holoenzyme and nanodiscs, andempty
nanodiscs, respectively. SDS-PAGE of these three
peaks is shown in Figure S1.
(B) Characterization of RIIb2:myrC2 holoenzyme
nanodiscs. (Left) Negatively stained electron
micrograph of the empty nanodiscs. (Right) Nega-
tively stained electron micrograph of the RIIb2:
myrC2 holoenzyme nanodiscs separated from the
empty one by size exclusion. Scale bar, 50 nm.Many signaling proteins are myristylated, and myristylation
is essential for membrane binding and proper cellular localiza-
tion of some proteins (Li et al., 2007; Song et al., 1997). The
bivalent membrane targeting of RII holoenzymes opens the
door to specific lipid interactions with farnesylation, palmitic
acid moiety, and the myristylation site of other membrane pro-
teins (Bohm et al., 1997). These potential interactions at mem-
brane sites may provide an additional platform to assemble
PKA. The association of the myristyl groups on the C subunit
in the RII holoenzyme with lipids or other lipid-anchored pro-
teins may provide a means for the C subunits to remain bound
to or in close proximity to the RII subunits, even in the pres-
ence of cAMP.EXPERIMENTAL PROCEDURES
Purification of the R and C Subunit Proteins
The non-myristylated C subunit was expressed and purified as described
previously (Herberg et al., 1993). Preparation of the myristylated C subunit
by co-expression with yeast N-myristyl transferase (Duronio et al., 1990)
and the purification protocol were also described previously (Bastidas
et al., 2012). We used a cysteine mutation at the N terminus of the myrC sub-
unit (K7C). As previously described (Bastidas et al., 2012), this mutation pro-
vides several advantages for studying the effects of N-terminal myristylation.
It blocks autophosphorylation of Ser10 by eliminating the PKA recognition
sequence at Ser10. Eliminating Ser10 phosphorylation increased the total
yield of myristylated protein, since myristylation and Ser10 phosphorylation
typically do not occur together in our bacterial co-expression system, which
was also observed previously with the recombinant myristylated protein. The
K7C mutation also appears to have a more stable N terminus based on time-
resolved fluorescence anisotropy, which helped to structurally characterize
the effects of N-myristylation in crystals. The structure of the K7C mutant
was very similar to the wild-type C subunit (Bastidas et al., 2012). Expression
and purification of the RIa and RIa(91–379:R333K) mutant as well as forma-
tion and purification of the RC heterodimers were described previously (Kim
et al., 2007) with the exception that holoenzyme was formed using ATP and
magnesium instead of adenylyl imidodiphosphate (AMP-PNP)/Mn. RIIb was
overexpressed in Escherichia coli and purified as described earlier (Zhang
et al., 2012). RIIb and wild-type C subunit were mixed in a molar ratio of
1:1.2 and spin dialyzed at 4C into holoenzyme buffer containing 20 mM
2-(N-morpholino)ethanesulfonic acid (MES) (pH 5.8), 50 mM NaCl, and
1 mM tris(2-carboxyethyl)phosphine hydrochloride. The complex was then
gel filtered through Superdex 200 in the same holoenzyme buffer to remove
excess C subunit.
Crystallization of RIa(91–379,R333K):myrC(K7C) Heterodimer
The same crystallization conditions used for the previous RIa(91–
379,R333K):C heterodimer (Kim et al., 2007) were utilized for this crystal struc-
ture. Specifically, the RC heterodimer was concentrated to 14 mg/ml andStructure 23, 1563–15screened for crystallization using the hanging-drop vapor diffusion method
against different ammonium sulfate concentrations, which ranged from 0.8
to 2.5 M in 0.1 M sodium citrate buffer, while the pH was varied from 5.0 to
6.0. The crystal used for structure determination was obtained from a 4-ml
drop containing 1:1 protein-to-well solution with the well solution containing
1.6 M ammonium sulfate and 0.1 M sodium citrate (pH 5.5).
Crystallization of RIIb(R230K)2:myrC(K7C)2 Holoenzyme
The same crystallization conditions used for the previous RIIb holoenzyme
(Zhang et al., 2012) were utilized for this crystal structure. Specifically, crystals
were obtained from RIIb holoenzyme that was concentrated to 12 mg/ml.
The crystal used for structure determination was obtained from a 3-ml drop
containing 1:1 protein-to-well solution with the well solution containing 10%
PEG8000, 8% ethylene glycol, and 20 mM MES (pH 5.8).
Data Collection and Refinement
Data were collected on the synchrotron beamline 8.2.1 of the Advanced
Light Source, Lawrence Berkeley National Labs (Berkeley, CA). The crystals
were flash-frozen in cryoprotectant conditions (well solution containing
20% glycerol for the RIa:C crystals and 30% PEG8000 for the RIIb holoen-
zyme crystals). The collected datasets were processed using the HKL2000
program package (Otwinowski and Minor, 1997). For the RIa(91–
379,R333K):myrC(K7C) datasets, phasing was performed using molecular
replacement with PDB: 2QCS (Kim et al., 2007) as a search model. For the
RIIb(R230K)2:myrC(K7C)2 datasets, phasing was performed using molecular
replacement with PDB: 3NTP (Zhang et al., 2012) as a search model. Refine-
ment was initially performed using Refmac (Vagin et al., 2004) in the CCP4
program package (Winn et al., 2011). Subsequently, refinement was per-
formed using PHENIX (Adams et al., 2010) to further improve the protein
geometry. Model building was done in Coot (Emsley and Cowtan, 2004).
The RIa(91–379,R333K):myrC(K7C)structure and RIIb(R230K)2:myrC(K7C)2
structure were refined to Rwork/Rfree values of 18.4%/23.4% and 19.8%/
26.1%, respectively. The data collection and refinement statistics are shown
in Table 1.
PKA Nanodisc Assembly and Purification
PKA nanodiscs were assembled based on a protocol adapted from previous
publications (Nath et al., 2007; Ye et al., 2010). In brief, 1,2-dimyristoyl-
sn-glycero-3-phosphocholine and 1,2-dimyristoyl-sn-glycero-3-phosphoryl-
30-rac-glycerol were solubilized in chloroform or a chloroform/methanol
mixture, mixed thoroughly, and dried onto a glass tube under steady
flow of nitrogen. The homogeneous lipid mixture was then solubilized in
100 mM cholate in 10 mM Tris and 100 mM NaCl (pH 7.4), giving a lipid con-
centration of 50 mM. 72 ml of the lipid solution was then mixed with 200 ml of
200 mM MSP in dH2O and 200 ml of 10 mM purified PKA holoenzyme. The
final ratio of lipids/MSP/protein was 90:1:0.05 in a total volume of 472 ml.
The PKA nanodiscs were assembled by removing the detergents with
SM-2 Biobeads overnight at room temperature. The assembled PKA nano-
discs were then purified with a Hi-load 16/60 Superdex 200 size-exclusion
column with 20 mM Tris, 150 mM NaCl, 0.5 mM MgCl2, and 10 mM AMP-
PNP (pH 7.4) for RI and 20 mM MES and 150 mM NaCl (pH 5.8) for RII, as
the column buffer. Different buffers were used for RI and RII to obtain stable72, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1569
Figure 6. PKA Has a Dynamic and Isoform-
Specific Myristylation Switch
(A) Potential role of Ser10 in stabilizing the N ter-
minus of myrC subunit. (Left) The distance
between the Ser10 side chain and the backbone
carbonyl of residue 7 is displayed, showing that
the atoms are in H-bonding distance in the
myrC(K7C):SP20 (tan) (PDB: 4DFX) and wild-type
myrC:SP20 structures (teal) (PDB: 4DG2). These
two structures are aligned with the backbone
atoms of residue 7 and side chain of Ser10,
shown in stick representation. (Right) Interactions
of Ser10 side chain and Cys7 and Ala6 in the
myrC(K7C):RIa(K7C) structure.
(B) The three myristylated structures presented
here are aligned. The conformation and B-factor
analysis of themyristic acid andMyrmotif can be in
two distinct ‘‘IN’’ and ‘‘OUT’’ modes. The myristic
acid and Myr motif in SP20:myrC (PDB: 4DFX),
RIa:myrC, and RIIb2:myrC2 are shown. On the right
is the scale bar for B factors.protein. The PKA RII holoenzyme nanodiscs and empty nanodiscs were
readily separated, and the successful assembly was verified by SDS-PAGE
analysis. When necessary, the nanodiscs were further concentrated using
Ultracel-30k (Millipore).
Negatively Stained Electron Microscopy Images of PKA Nanodiscs
Purified nanodiscs were diluted to 10 mg/ml and 3 ml of the diluted sample
was applied to a glow-discharged carbon grid. The protein sample was ab-
sorbed for 30 s and blotted away. The grid was then washed and stained
with 2% uranyl acetate. The grids were left to air dry and loaded into a Tecnai
G2 Sphera microscope (FEI) equipped with a LaB6 electron gun and a Gatan
Ultrascan 1000 UHS CCD camera (Gatan) for analysis. Images of nanodiscs
were taken at a voltage of 200 kV and a magnification of 65,0003 in Digital
Micrograph software (Gatan).1570 Structure 23, 1563–1572, September 1, 2015 ª2015 Elsevier LtACCESSION NUMBERS
Coordinates and structure factors have been deposited in the PDBwith acces-
sion numbers PDB: 4X6Q (RIIb2:myrC2) and 4X6R (RIa:myrC).
SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures and can be found with this
article online at http://dx.doi.org/10.1016/j.str.2015.07.007.
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